<DOC>
	<DOCNO>NCT02287350</DOCNO>
	<brief_summary>As part Pediatric Research Equity Act ( PREA ) commitment , objective study characterize pharmacokinetic ( PK ) profile determine safety tolerability diclofenac potassium oral solution pediatric subject experience mild moderate acute pain .</brief_summary>
	<brief_title>Pharmacokinetics &amp; Safety Diclofenac Potassium Oral Solution Ped . Subjects ( 2-12 Yrs ) With Mild-Mod . Acute Pain</brief_title>
	<detailed_description>This open-label study pediatric subject , age 2-12 year , dose diclofenac potassium oral solution , base weight , every 6 hour need treatment mild moderate acute pain 4 day . PK sample collect 6 hour first dose . Safety data collect throughout study .</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Male female subject 212 year age . Subjects must postop , mild moderate acute pain . Other inclusion apply . Subject known history allergic reaction , hypersensitivity diclofenac , aspirin , acetaminophen , reaction nonactive ingredient study medication . Subject take analgesic 4872 hour prior Screening . Subject history GI event great 6 month Screening . Subject currently receive medication contraindicate use concomitantly diclofenac acetaminophen . Subject require treatment preexist hypertension . Other exclusion apply .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>pain</keyword>
	<keyword>moderate pain</keyword>
	<keyword>mild pain</keyword>
	<keyword>acute pain</keyword>
	<keyword>mild acute pain</keyword>
	<keyword>moderate acute pain</keyword>
	<keyword>mild moderate acute pain</keyword>
	<keyword>NSAID</keyword>
	<keyword>nonsteroidal anti-inflammatory drug</keyword>
</DOC>